ArQule to Report Fiscal 2012 Financial Results on March 14, 2013

  ArQule to Report Fiscal 2012 Financial Results on March 14, 2013

Business Wire

WOBURN, Mass. -- March 7, 2013

ArQule, Inc. (NASDAQ: ARQL) today announced that it will report its financial
results for the fiscal 2012 year-end and fourth quarter on Thursday, March 14,
2013 at 7:00 a.m. eastern time. The Company will hold a conference call at
9:00 a.m. eastern time that day to discuss these results.

Conference Call and Webcast     
    Date:                       Thursday, March 14, 2013
        Time:                       9:00 a.m., Eastern Time
Conference Call Numbers
        Domestic (toll free):       (877) 868-1831
        International:              (914) 495-8595

A replay of the conference call will be available beginning on March 14, 2013
two hours after the call’s completion for seven days and can be accessed by
dialing toll-free (855) 859-2056 and outside the U.S. (404) 537-3406. The
confirmation code for replayed calls is 94647035.

About ArQule

ArQule is a biotechnology company engaged in the research and development of
next-generation, small-molecule cancer therapeutics. The Company’s targeted,
broad-spectrum products and research programs are focused on key biological
processes that are central to human cancers. ArQule’s lead product, in Phase 2
and Phase 3 clinical development, is tivantinib (ARQ 197), an oral, selective
inhibitor of the c-MET receptor tyrosine kinase. The Company’s pipeline
consists of ARQ 087, designed to inhibit fibroblast growth factor receptor
(FGFR), ARQ 621, designed to inhibit the Eg5 kinesin motor protein, and ARQ
736, designed to inhibit the RAF kinases. ArQule’s current discovery efforts,
which are based on the ArQule Kinase Inhibitor Platform (AKIP™), are focused
on the identification of novel kinase inhibitors that are potent, selective
and do not compete with ATP (adenosine triphosphate) for binding to the


ArQule, Inc.
William B. Boni, 781-994-0300
VP, Investor Relations/
Corp. Communications
Press spacebar to pause and continue. Press esc to stop.